Uloric and Solu-cortef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Uloric (febuxostat) and Solu-cortef (hydrocortisone sodium succinate). Common drug interactions include abdominal pain upper among females and infusion related reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Uloric and Solu-cortef. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Uloric?

Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 8,067 Uloric users. Check the latest studies of Uloric.

What is Solu-cortef?

Solu-cortef has active ingredients of hydrocortisone sodium succinate. eHealthMe is studying from 7,983 Solu-cortef users. Check the latest studies of Solu-cortef.

On Jul, 11, 2026

15 people who take Uloric and Solu-cortef together, and have interactions are studied.

Uloric and Solu-cortef drug interactions.

What are the common drug interactions of Uloric and Solu-Cortef, by gender? *:

female:

Abdominal pain upper
Ear infection
Food poisoning (poison in food)
Gastric infection (infection of stomach)
Infusion site pain
Kidney infection
Urinary tract infection
Weight increased
Infusion site haemorrhage (bleeding from infusion site)
Infusion site mass

male:

Infusion related reaction
Therapeutic response decreased (less preventive response)
Blood potassium decreased
Blood urea increased
Chills (felling of cold)
Decreased appetite
Diarrhoea
Drug ineffective
Hypotension (abnormally low blood pressure)
Ill-defined disorder

What are the common drug interactions of Uloric and Solu-Cortef, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Therapeutic response decreased (less preventive response)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Infusion related reaction

40-49:

Drug ineffective
Urticaria (rash of round, red welts on the skin that itch intensely)

50-59:

Infusion related reaction

60+:

Dehydration (dryness resulting from the removal of water)
Pyrexia (fever)
Chills (felling of cold)
Decreased appetite
Diarrhoea
Hypotension (abnormally low blood pressure)
Ill-defined disorder
Joint swelling
Pain
Rash generalised (rash on most of body parts)

What are the existing conditions these people have? *

Gouty Tophus (a deposit of urates in the skin and tissue around a joint or in the external ear): 4 people, 26.67%
Immunodeficiency Common Variable: 4 people, 26.67%
High Blood Cholesterol: 3 people, 20.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 13.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 13.33%
Constipation: 2 people, 13.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 13.33%
Diarrhea: 2 people, 13.33%
Heart Attack: 2 people, 13.33%
Cardiac Failure Congestive: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Uloric and Solu-cortef?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously